Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections
| Status: | Completed |
|---|---|
| Conditions: | Post-Surgical Pain, Ocular, Ocular |
| Therapuetic Areas: | Musculoskeletal, Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - 120 |
| Updated: | 12/19/2018 |
| Start Date: | October 12, 2016 |
| End Date: | April 2018 |
The specific aims of this study are to compare patient experience with and without a
proparacaine drop after povidone iodine. To ensure the extra drop does not interfere with
antisepsis, conjunctival cultures will be obtained from patients undergoing intravitreal
injection before and after the application of the extra eye drop. Patients will be randomized
to undergo additional topical analgesia during intravitreal injection vs. the standard amount
of topical analgesia. Cultures of the eyelid/conjunctiva will be taken to ensure that the
additional topical analgesia does not interfere with antisepsis.
proparacaine drop after povidone iodine. To ensure the extra drop does not interfere with
antisepsis, conjunctival cultures will be obtained from patients undergoing intravitreal
injection before and after the application of the extra eye drop. Patients will be randomized
to undergo additional topical analgesia during intravitreal injection vs. the standard amount
of topical analgesia. Cultures of the eyelid/conjunctiva will be taken to ensure that the
additional topical analgesia does not interfere with antisepsis.
Inclusion Criteria:
- patients undergoing intravitreal injection who do not have active eye infections
- greater than 18 years of age
Exclusion Criteria:
- patients younger than 18 years of age
- patients with active eye infections
We found this trial at
1
site
Click here to add this to my saved trials
